tetramethylpyrazine has been researched along with Liver Steatosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Y; Sun, X; Wang, X; Wang, Y; Xiang, Y; Xiao, F | 1 |
| Chen, L; Chen, Q; Jin, H; Lu, C; Lu, Y; Shao, J; Wu, L; Xu, W; Zhang, F; Zheng, S | 1 |
2 other study(ies) available for tetramethylpyrazine and Liver Steatosis
| Article | Year |
|---|---|
2,3,5,6-Tetramethylpyrazine improves diet-induced whole-body insulin resistance via suppressing white adipose tissue lipolysis in mice.
Topics: Adipose Tissue, White; Animals; Diet, High-Fat; Fatty Liver; Glucose; Insulin Resistance; Lipolysis; Male; Mice; Muscle, Skeletal; Pyrazines | 2020 |
Ligustrazine prevents alcohol-induced liver injury by attenuating hepatic steatosis and oxidative stress.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Fatty Liver; Liver Diseases, Alcoholic; Male; Oxidative Stress; Pyrazines; Rats; Rats, Sprague-Dawley | 2015 |